Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.
about
Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureusDo we need an intravenous fluoroquinolone?Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.In vitro antibacterial activity of Q-35, a new fluoroquinoloneComparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infectionIn vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance risesIdentification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadioneExamination of methicillin-resistant and methicillin-susceptible Staphylococcus aureus mutants with low-level fluoroquinolone resistanceTOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureusComparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.Activities of newer fluoroquinolones against Shigella sonnei.A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
P2860
Q28539903-B8E2BD90-DA25-4437-9AA5-2FE1DBD4F6CEQ33606570-D87C770B-2BA4-42D2-A14E-CF4714E2FD45Q34333286-EBE50840-FF8C-4C6A-AD55-5CD0986F192EQ34537973-E10460EE-5358-4D08-8ACD-D31112476668Q35821605-38DC8D7E-AE1D-4643-BDE9-6A82436BFE8FQ36757105-1FC9EAC6-7BB8-4067-BFE4-91361B33C2CDQ36949434-8C0F72D5-29FE-4C38-86BB-36C0E3C4C7FAQ37713222-A4C02E59-8598-4551-8E74-5F77E40E7BC8Q39559760-83FF7B70-22EC-480B-8D10-C4E5AF0F6388Q39779720-3E8D0B6D-7820-48B1-B228-08408FA401C5Q40088541-DDFA9E93-BA36-403F-A52E-D353C8885BAEQ40088690-11A6A0DF-25D3-42C1-A90A-F721DB3CA8F6Q41646436-3B8D0295-5F9E-47F0-9F96-8820F91726C8
P2860
Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Differing activities of quinol ...... sistant Staphylococcus aureus.
@en
type
label
Differing activities of quinol ...... sistant Staphylococcus aureus.
@en
prefLabel
Differing activities of quinol ...... sistant Staphylococcus aureus.
@en
P2093
P2860
P356
P1476
Differing activities of quinol ...... sistant Staphylococcus aureus.
@en
P2093
Brumfitt W
Hamilton-Miller JM
P2860
P304
P356
10.1128/AAC.35.2.345
P407
P577
1991-02-01T00:00:00Z